Published on Apr 8, 2014
Takeda has been fined $6bn over alleged health risks of its Actos diabetes treatment. Eli Lilly, its US partner, must pay $3bn. Lex’s Oliver Ralph and Robert Armstrong discuss whether the drugs companies can recover from such hefty penalties.
Note: These corporations in their remorseless pursuit of profit at the behest of their investors and board have lost any moral or social capital to lead or dictate to humanity what is in our best interests.
Uploaded on Dec 17, 2010
A new study by the watchdog group Public Citizen has found that the pharmaceutical drug industry has become the biggest defrauder of the federal government, surpassing the defense industry. Public Citizen found that the drug industry paid out nearly $20 billion in penalties over the past two decades for violations of the False Claim Act. More than half of the industry’s fines were paid by just four companies: GlaxoSmithKline, Pfizer, Eli Lilly and Schering-Plough.
“…We help you recruit drug naive subjects in many developing countries”
This is a brief overview of the entire pharmaceutical industry. It includes an examination of the financial records of 14 of the world’s largest pharmaceutical companies over an 11 year period
“…went over records of 14 of these major pharmaceutical companies, going back 11 years 2003 to 2013…$4.44 Trillion in Revenue…$735 Billion on research…$1.3 Trillion on marketing…their profits, $853 Billion…”